Skip to main content
Tempus AI10-Q: AI investment

Acquisition of Personalis reinforces strategic investment in AI and large-scale genomics data.

What happened

The merger with genomics firm Personalis, Inc. is a strategic move to enhance Tempus's AI capabilities and data assets for precision medicine.

Source

SEC EDGARJul 30, 2026

Quarterly report (Form 10-Q)

Tempus AI 10-Q

Filing excerpt

Agreement and Plan of Merger, dated as of July 20, 2026 by and among Tempus AI, Inc., Personalis, Inc., Aviary Development, Inc. and Toucan Development, LLC.

sec.gov/Archives/edgar/data/1717115/000119312526326090/tem-20260630.htmRead the full source

Other signals in this filing (7)

Extracted by Autobound

From the Signal API record
Signal
10-Q: AI investment

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
06/30
Filed
Jul 30, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
1717115
Accession number
0001193125-26-326090
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Target for AI vendors
Signal category
Technology

Topics and mentions

Technologies

  • AI
  • genomics

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
Aug 4, 2026
signal_type
sec-10q
signal_subtype
aiInvestment

Use this data

Get every 10-Q signal for Tempus AI and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Tempus AI this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/20df0e8f-fd04-42bd-b18d-0d4ac25733c6 returns this record as JSON. POST /v1/companies/enrich returns every signal for tempus.com.

{
  "signal_id": "20df0e8f-fd04-42bd-b18d-0d4ac25733c6",
  "signal_type": "sec-10q",
  "signal_subtype": "aiInvestment",
  "detected_at": "2026-08-04T07:04:50.444+00:00",
  "company": {
    "name": "Tempus AI",
    "domain": "tempus.com"
  },
  "data": {
    "detail": "The merger with genomics firm Personalis, Inc. is a strategic move to enhance Tempus's AI capabilities and data assets for precision medicine. This signals a continued high-priority focus on AI/ML development, creating opportunities for MLOps, data labeling, and high-performance computing vendors.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "Acquisition of Personalis reinforces strategic investment in AI and large-scale genomics data.",
    "excerpts": "Agreement and Plan of Merger, dated as of July 20, 2026 by and among Tempus AI, Inc., Personalis, Inc., Aviary Development, Inc. and Toucan Development, LLC.",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1717115/000119312526326090/tem-20260630.htm",
    "filing_date": "2026-07-30",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "06/30",
    "sales_relevance": "Target for AI vendors",
    "signal_category": "technology",
    "technologies_mentioned": [
      "AI",
      "genomics"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.